Literature DB >> 21607160

Therapeutic potential of curcumin in gastrointestinal diseases.

Sigrid A Rajasekaran1.   

Abstract

Curcumin, also known as diferuloylmethane, is derived from the plant Curcuma longa and is the active ingredient of the spice turmeric. The therapeutic activities of curcumin for a wide variety of diseases such as diabetes, allergies, arthritis and other chronic and inflammatory diseases have been known for a long time. More recently, curcumin's therapeutic potential for preventing and treating various cancers is being recognized. As curcumin's therapeutic promise is being explored more systematically in various diseases, it has become clear that, due to its increased bioavailability in the gastrointestinal tract, curcumin may be particularly suited to be developed to treat gastrointestinal diseases. This review summarizes some of the current literature of curcumin's anti-inflammatory, anti-oxidant and anti-cancer potential in inflammatory bowel diseases, hepatic fibrosis and gastrointestinal cancers.

Entities:  

Keywords:  Apoptosis; Cancer; Curcumin; Gastrointestinal disease; Inflammation; Inflammatory bowel disease; Liver fibrosis

Year:  2011        PMID: 21607160      PMCID: PMC3097964          DOI: 10.4291/wjgp.v2.i1.1

Source DB:  PubMed          Journal:  World J Gastrointest Pathophysiol        ISSN: 2150-5330


  186 in total

1.  Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity.

Authors:  Shahar Lev-Ari; Alex Starr; Akiva Vexler; Vicki Karaush; Vered Loew; Joel Greif; Eyal Fenig; Dan Aderka; Rami Ben-Yosef
Journal:  Anticancer Res       Date:  2006 Nov-Dec       Impact factor: 2.480

2.  Retardation of experimental tumorigenesis and reduction in DNA adducts by turmeric and curcumin.

Authors:  K Krishnaswamy; V K Goud; B Sesikeran; M A Mukundan; T P Krishna
Journal:  Nutr Cancer       Date:  1998       Impact factor: 2.900

3.  Reduction of periductal fibrosis in liver fluke-infected hamsters after long-term curcumin treatment.

Authors:  Somchai Pinlaor; Suksanti Prakobwong; Yusuke Hiraku; Porntip Pinlaor; Umawadee Laothong; Puangrat Yongvanit
Journal:  Eur J Pharmacol       Date:  2010-04-24       Impact factor: 4.432

4.  Curcumin synergizes with resveratrol to inhibit colon cancer.

Authors:  Adhip P N Majumdar; Sanjeev Banerjee; Jyoti Nautiyal; Bhaumik B Patel; Vaishali Patel; Jianhua Du; Yingjie Yu; Althea A Elliott; Edi Levi; Fazlul H Sarkar
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

5.  Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.

Authors:  T Kawamori; R Lubet; V E Steele; G J Kelloff; R B Kaskey; C V Rao; B S Reddy
Journal:  Cancer Res       Date:  1999-02-01       Impact factor: 12.701

6.  Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation.

Authors:  Yumei Fu; Shizhong Zheng; Jianguo Lin; Jan Ryerse; Anping Chen
Journal:  Mol Pharmacol       Date:  2007-11-15       Impact factor: 4.436

7.  The upregulation of heat shock protein 70 expression in areca quid chewing-associated oral squamous cell carcinomas.

Authors:  Shiuan-Shinn Lee; Chung-Hung Tsai; Yung-Chuan Ho; Yu-Chao Chang
Journal:  Oral Oncol       Date:  2008-01-30       Impact factor: 5.337

8.  Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats.

Authors:  M A Pereira; C J Grubbs; L H Barnes; H Li; G R Olson; I Eto; M Juliana; L M Whitaker; G J Kelloff; V E Steele; R A Lubet
Journal:  Carcinogenesis       Date:  1996-06       Impact factor: 4.944

Review 9.  Curcumin as "Curecumin": from kitchen to clinic.

Authors:  Ajay Goel; Ajaikumar B Kunnumakkara; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2007-08-19       Impact factor: 5.858

10.  Curcumin induces apoptosis through mitochondrial hyperpolarization and mtDNA damage in human hepatoma G2 cells.

Authors:  Jun Cao; Yong Liu; Li Jia; Hui-Min Zhou; Ying Kong; Guang Yang; Li-Ping Jiang; Qiu-Juan Li; Lai-Fu Zhong
Journal:  Free Radic Biol Med       Date:  2007-06-13       Impact factor: 7.376

View more
  25 in total

1.  Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients.

Authors:  Julie L Ryan; Charles E Heckler; Marilyn Ling; Alan Katz; Jacqueline P Williams; Alice P Pentland; Gary R Morrow
Journal:  Radiat Res       Date:  2013-06-07       Impact factor: 2.841

2.  In Vitro-In Vivo Dose Response of Ursolic Acid, Sulforaphane, PEITC, and Curcumin in Cancer Prevention.

Authors:  Christina N Ramirez; Wenji Li; Chengyue Zhang; Renyi Wu; Shan Su; Chao Wang; Linbo Gao; Ran Yin; Ah-Ng Kong
Journal:  AAPS J       Date:  2017-12-20       Impact factor: 4.009

3.  A Systematic Review of the Clinical Use of Curcumin for the Management of Gastrointestinal Diseases.

Authors:  Masoumeh Atefi; Mina Darand; Mohammad Hassan Entezari; Tannaz Jamialahmadi; Mohammad Bagherniya; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases.

Authors:  Avijit Sarkar; Ronita De; Asish K Mukhopadhyay
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

5.  Preparation and characterization of curcumin-piperine dual drug loaded nanoparticles.

Authors:  C Moorthi; Kiran Krishnan; R Manavalan; K Kathiresan
Journal:  Asian Pac J Trop Biomed       Date:  2012-11

6.  Correction to: In Vitro-In Vivo Dose Response of Ursolic Acid, Sulforaphane, PEITC, and Curcumin in Cancer Prevention.

Authors:  Christina N Ramirez; Wenji Li; Chengyue Zhang; Renyi Wu; Shan Su; Chao Wang; Linbo Gao; Ran Yin; Ah-Ng Tony Kong
Journal:  AAPS J       Date:  2018-02-06       Impact factor: 4.009

Review 7.  Cancer prevention with promising natural products: mechanisms of action and molecular targets.

Authors:  Poyil Pratheeshkumar; Chakkenchath Sreekala; Zhuo Zhang; Amit Budhraja; Songze Ding; Young-Ok Son; Xin Wang; Andrew Hitron; Kim Hyun-Jung; Lei Wang; Jeong-Chae Lee; Xianglin Shi
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

Review 8.  Matrix metalloproteinases and gastrointestinal cancers: Impacts of dietary antioxidants.

Authors:  Sugreev Verma; Kousik Kesh; Nilanjan Ganguly; Sayantan Jana; Snehasikta Swarnakar
Journal:  World J Biol Chem       Date:  2014-08-26

9.  A combined treatment of curcumin, piperine, and taurine alters the circulating levels of IL-10 and miR-21 in hepatocellular carcinoma patients: a pilot study.

Authors:  Hala M Hatab; Fatma F Abdel Hamid; Ahmed F Soliman; Tamer A Al-Shafie; Yahia M Ismail; Motawa E El-Houseini
Journal:  J Gastrointest Oncol       Date:  2019-08

10.  Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: a randomized, double-blind, placebo-controlled prospective study.

Authors:  Yasuaki Nakagawa; Shogo Mukai; Shigeru Yamada; Masayuki Matsuoka; Eri Tarumi; Tadashi Hashimoto; Chieko Tamura; Atsushi Imaizumi; Jun Nishihira; Takashi Nakamura
Journal:  J Orthop Sci       Date:  2014-10-13       Impact factor: 1.601

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.